Clinical Trial Update: Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty [Phase 2]

View source ↗

Summary

This clinical trial update documents a Phase 2 study evaluating how immunosuppressants should be managed in rheumatic disease patients undergoing elective total…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatic Disease

Snippet

Sponsor: NYU Langone Health | Conditions: Rheumatic Disease | Phase 2 | Status: NOT_YET_RECRUITING